This is not a vintage year for unit trust performance. In the first nine months less than 30 per cent of funds listed by Standard & Poor's Investors Services are making a profit. Many of those making money invest in sectors unlikely to attract the average Hong Kong investor.
Products based on biotechnology and health-care stocks have led the way up, while down in the performance dungeons are the very stocks which once provided Asian investors with stunning performances - single Asian country products, Japanese technology plays and regional funds.
The hardest hit investors have seen up to 70 per cent wiped off the value of their funds this year.
Once again, it is time to rehearse that old mantra beloved by the grey-bearded advisors but so often derided by the whiz-kids: diversify, diversify, diversify.
Simple enough advice, but in practical terms, how do investors spread the risk? Is it best to buy a single global fund, managed by one group, or build a whole portfolio of funds based on different geographical or industrial sectors?
Finding one fund manager who can provide consistent performance is difficult enough, picking a posse of them is even more daunting.
